When to biopsy and when to stop biopsying
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 30 (2) , 253-262
- https://doi.org/10.1016/s0094-0143(02)00188-x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Novel Artificial Neural Network for Early Detection of Prostate CancerJournal of Clinical Oncology, 2002
- OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MENJournal of Urology, 2000
- NONPALPABLE STAGE T1C PROSTATE CANCER: PREDICTION OF INSIGNIFICANT DISEASE USING FREE/TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS AND NEEDLE BIOPSY FINDINGSJournal of Urology, 1998
- Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levelsThe Prostate, 1998
- PROSTATE CANCER DIAGNOSED BY THE 5 REGION BIOPSY METHOD IS SIGNIFICANT DISEASEJournal of Urology, 1998
- REPEAT ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSY: USE OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN RATIO IN PREDICTING PROSTATIC CARCINOMAJournal of Urology, 1998
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Role of psa and its indices in determining the need for repeat prostate biopsiesUrology, 1997
- Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigenUrology, 1996
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991